CY1224A - Neue tetralinderivate,ihre herstellung und verwendung - Google Patents

Neue tetralinderivate,ihre herstellung und verwendung

Info

Publication number
CY1224A
CY1224A CY1224A CY122478A CY1224A CY 1224 A CY1224 A CY 1224A CY 1224 A CY1224 A CY 1224A CY 122478 A CY122478 A CY 122478A CY 1224 A CY1224 A CY 1224A
Authority
CY
Cyprus
Prior art keywords
tetralinderivate
neue
herstellung und
und verwendung
ihre herstellung
Prior art date
Application number
CY1224A
Other languages
English (en)
Inventor
Max-Peter Dr Seiler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CY1224A publication Critical patent/CY1224A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CY1224A 1977-07-18 1978-07-11 Neue tetralinderivate,ihre herstellung und verwendung CY1224A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH886377 1977-07-18
CH1358377 1977-11-08

Publications (1)

Publication Number Publication Date
CY1224A true CY1224A (en) 1984-04-06

Family

ID=25703869

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1224A CY1224A (en) 1977-07-18 1978-07-11 Neue tetralinderivate,ihre herstellung und verwendung

Country Status (17)

Country Link
US (1) US4308266A (fr)
EP (1) EP0000395B1 (fr)
JP (1) JPS5422383A (fr)
AU (1) AU521642B2 (fr)
CA (1) CA1131641A (fr)
CY (1) CY1224A (fr)
DE (1) DE2860410D1 (fr)
DK (1) DK309678A (fr)
ES (2) ES471809A1 (fr)
FI (1) FI68821C (fr)
HK (1) HK85184A (fr)
IE (1) IE47129B1 (fr)
IL (1) IL55153A (fr)
IT (1) IT1105089B (fr)
NZ (1) NZ187876A (fr)
PH (1) PH17238A (fr)
PT (1) PT68306A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590274A (en) * 1985-01-03 1986-05-20 E. I. Du Pont De Nemours And Company Antihypertensive 1-[bis-(substituted phenyl)methyl]-4[2-(1,2,3,4-tetrahydro-substituted naphthalen-1-ylidene)ethyl]piperazines
WO1987002035A1 (fr) * 1985-10-04 1987-04-09 Maggioni-Winthrop S.P.A. Aminoalcools cycloaliphatiques fusionnes
GB8615560D0 (en) * 1986-06-25 1986-07-30 Maggioni Farma Aminoalcohols
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins
CA1335591C (fr) * 1988-05-23 1995-05-16 James Arthur Nixon Derives de subtitution sur le cycle de 2-amino-1,2,3,4-tetrahydronaphtalenes
US4988699A (en) * 1989-03-14 1991-01-29 Warner-Lambert Company Substituted tetrahydrobenzothiazoles as dopaminergic agents
GB8907865D0 (en) * 1989-04-07 1989-05-24 Wyeth John & Brother Ltd Tetrahydroquinoline derivatives
US5194439A (en) * 1990-04-06 1993-03-16 John Wyeth & Brother Limited N-(2,3-dihydro-1,4-benzodioxinyl)-N-substituted aminopyrido-fused cycloalkanes
GB2290790A (en) * 1994-06-30 1996-01-10 Merck & Co Inc Asymmetric synthesis of 6-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1190466B (de) * 1961-11-07 1965-04-08 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Piperazinderivaten
CA969955A (en) * 1970-07-20 1975-06-24 Rene Viterbo Dihydronaphthalene derivatives
US4018773A (en) * 1975-09-15 1977-04-19 E. R. Squibb & Sons, Inc. Phenylpiperazinotetrahydronaphthols and derivatives

Also Published As

Publication number Publication date
FI68821C (fi) 1985-11-11
CA1131641A (fr) 1982-09-14
US4308266A (en) 1981-12-29
DK309678A (da) 1979-01-19
ES479059A1 (es) 1979-07-01
IE781438L (en) 1979-01-18
IT1105089B (it) 1985-10-28
IE47129B1 (en) 1983-12-28
JPS5422383A (en) 1979-02-20
IT7850272A0 (it) 1978-07-13
NZ187876A (en) 1981-02-11
IL55153A0 (en) 1978-09-29
AU521642B2 (en) 1982-04-22
HK85184A (en) 1984-11-16
FI68821B (fi) 1985-07-31
PT68306A (fr) 1978-08-01
FI782202A (fi) 1979-01-19
EP0000395B1 (fr) 1981-01-07
DE2860410D1 (en) 1981-02-26
IL55153A (en) 1983-07-31
ES471809A1 (es) 1979-10-01
EP0000395A1 (fr) 1979-01-24
AU3808678A (en) 1980-01-17
PH17238A (en) 1984-07-03

Similar Documents

Publication Publication Date Title
ZA785001B (en) 1-phenyl-2-azolyl-4,4-dimethyl-1-penten-3-ols
GB2007213B (en) 2,6-diaminoebularins
MY8500284A (en) 6,7-dial koxy-4(4-substituted-piperidino)-quinazolines
GB2007643B (en) 4,5-diarylthiazoles
PH14778A (en) 4d,5d-epoxy 17b-hydroxy-4,17-dimethyl-3-oxo-androstane-2d-carbonitrile
ZA781885B (en) Interphenylene 8-aza-9-dioxothia-11,12-secoprostaglandins
CS526878A2 (en) Zpusob zpracovani pryzoveho odpadu,zejmena opotrebenych automobilovych pneumatik
CY1224A (en) Neue tetralinderivate,ihre herstellung und verwendung
AU4127478A (en) 6-oxygenated-3,2-dioxo-pregnane-derivatives
IL54358A0 (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides
GB2058066B (en) 6h-1,3,4-thiadiazine-2-amines
GB2085872B (en) 13,14-didehydro-prostaglandins
GB2086882B (en) 2,4-diamino-5-benzyl-6-halogenpyrimidines
GB1516024A (en) Thiophene-2,5-disulphonamides
IL55865A0 (en) 4-desacetoxy-4-oxovinblastine, 4-descetoxy-4-alpha-hydroxyvinblastine and related compounds
IL59162A0 (en) 25-hydroxycholecalciferol-26,23-lactone
GB2001972B (en) Substituted 1-piperazinyl-triazolo-thieno-1,4-diazepines
GB2040932B (en) 1 - substituted - 3,4 - epoxypyrrolidines
GB1542605A (en) 4-tertiary-amino-2,6-diaminopyridine-1-oxides
IE45999L (en) 2-methoxybenzamides.
GB2037770B (en) 3,4,5 - trihydroxy - 5 - (2,3 - epoxy - 5-hydroxy - 4 - methyl - hexyl) - tetra-hydropyran - 2 - yl - acetone
AU3857578A (en) Biocidally-active 1, 3-benzodithiole-2-thione compounds
CS375378A1 (en) Zpusob montaze nosnych dilcu uloznych skladovych konstrukci, zejmena skladovych regalu
IE780092L (en) Phenylazacycloalkanes.
ZA781345B (en) New 2,46-trisubstituted-2,3-dihydro-benzofuran derivatives